oxybutynin has been researched along with Acute Thrombotic Stroke in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Men with locally advanced or metastatic prostate cancer were randomly allocated (1:2 from August, 2007 then 1:1 from February, 2011) to either LHRHa according to local practice or tE2 patches (four 100 μg patches per 24 h, changed twice weekly, reducing to three patches twice weekly if castrate at 4 weeks [defined as testosterone ≤1·7 nmol/L])." | 3.01 | Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. ( Alhasso, A; Clarke, NW; Collins, GN; Deighan, JV; Dixit, S; Duong, T; Forcat, S; Gilbert, DC; Kockelbergh, R; Kynaston, H; Langley, RE; Laniado, ME; Macnair, A; Madaan, S; Manetta, C; Mangar, S; Marshall, J; McFarlane, J; Mckay, S; Muazzam, IA; Nankivell, M; Paez, E; Parmar, M; Pope, A; Robinson, A; Rosen, SD; Scrase, CD; Sundaram, SK; Weiss, M; Williams, ST; Worlding, J, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Langley, RE | 1 |
| Gilbert, DC | 1 |
| Duong, T | 1 |
| Clarke, NW | 1 |
| Nankivell, M | 1 |
| Rosen, SD | 1 |
| Mangar, S | 1 |
| Macnair, A | 1 |
| Sundaram, SK | 1 |
| Laniado, ME | 1 |
| Dixit, S | 1 |
| Madaan, S | 1 |
| Manetta, C | 1 |
| Pope, A | 1 |
| Scrase, CD | 1 |
| Mckay, S | 1 |
| Muazzam, IA | 1 |
| Collins, GN | 1 |
| Worlding, J | 1 |
| Williams, ST | 1 |
| Paez, E | 1 |
| Robinson, A | 1 |
| McFarlane, J | 1 |
| Deighan, JV | 1 |
| Marshall, J | 1 |
| Forcat, S | 1 |
| Weiss, M | 1 |
| Kockelbergh, R | 1 |
| Alhasso, A | 1 |
| Kynaston, H | 1 |
| Parmar, M | 1 |
1 trial available for oxybutynin and Acute Thrombotic Stroke
| Article | Year |
|---|---|
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
Topics: Acute Coronary Syndrome; Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Embolic Stro | 2021 |